PEREGRINE PHARMACEUTICALS INC 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed May 12, 2015
Insider Transaction Report
Form 4
POHL DAVID
Director
Transactions
- Award
Stock Option (right to buy)
2015-05-11+187,500→ 1,719,500 totalExercise: $1.31From: 2015-08-11Exp: 2025-05-11→ Common Stock (187,500 underlying)
Footnotes (1)
- [F1]This option vests in eight (8) equal quarterly installments over a two (2) year period beginning August 11, 2015 and each quarter thereafter until fully-vested.